D-0817-2018 Class II Terminated
FDA drug recall D-0817-2018 was initiated by Perrigo New York on May 7, 2018 and is designated Class II. Reason for recall: Failed Stability Specifications The recall status is terminated (terminated Dec 10, 2018). Affected quantity: 571,632 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- May 23, 2018
- Initiation Date
- May 7, 2018
- Termination Date
- Dec 10, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 571,632 tubes
Product description
Hydrocortisone Ointment, USP 2.5%, Net Wt. 20g, Rx Only, Manufactured By Perrigo, Bronx, NY 10457, Distributed by Perrigo, Allegan MI 49010, NDC 45802-014-02
Reason for recall
Failed Stability Specifications
Distribution pattern
US Nationwide including Puerto Rico.
Code information
Lot Numbers: 7AT0283V, exp. 11/18 7AT0284V, exp. 11/18 7AT0285V, exp. 11/18 7FT0460, exp. 05/19 7FT0461, exp. 05/19 7GT0465, exp. 06/19 7GT0466, exp. 06/19 7JT0390, exp. 08/19 7JT0392, exp. 08/19 7KT0588, exp. 09/19 7KT0589, exp. 09/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0817-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026